The Middle EAST Molecular Diagnostics Market was valued at USD 2.5 billion in 2024 and is projected to reach USD 5.8 billion by 2034, registering a CAGR of 8.9%. This growth trajectory is underpinned by several factors, including the increasing prevalence of infectious diseases, rising awareness regarding personalized medicine, and advancements in technology that enhance diagnostic accuracy and...